Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications

Am Heart J. 1982 Mar;103(3):401-14. doi: 10.1016/0002-8703(82)90281-2.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Amitriptyline / adverse effects
  • Amitriptyline / blood
  • Amitriptyline / therapeutic use
  • Antidepressive Agents, Tricyclic / adverse effects
  • Antidepressive Agents, Tricyclic / blood
  • Antidepressive Agents, Tricyclic / therapeutic use*
  • Arrhythmias, Cardiac / chemically induced
  • Arrhythmias, Cardiac / mortality
  • Cardiovascular System / drug effects*
  • Child
  • Depression / drug therapy
  • Depression / mortality
  • Depression / physiopathology
  • Desipramine / adverse effects
  • Desipramine / blood
  • Desipramine / therapeutic use
  • Doxepin / adverse effects
  • Doxepin / blood
  • Doxepin / therapeutic use
  • Electrocardiography
  • Hemodynamics / drug effects
  • Humans
  • Hypotension / chemically induced
  • Hypotension / mortality
  • Imipramine / adverse effects
  • Imipramine / blood
  • Imipramine / therapeutic use
  • Kinetics
  • Middle Aged
  • Myocardium / metabolism
  • Norepinephrine / metabolism
  • Parasympatholytics / pharmacology
  • Protriptyline / adverse effects
  • Protriptyline / blood
  • Protriptyline / therapeutic use

Substances

  • Antidepressive Agents, Tricyclic
  • Parasympatholytics
  • Doxepin
  • Amitriptyline
  • Protriptyline
  • Imipramine
  • Desipramine
  • Norepinephrine